Nomura Holdings’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.48M | Sell |
16,000
-20,000
| -56% | -$4.44M | 0.01% | 737 |
|
|
2025
Q4 | $8.23M | Buy |
36,000
+16,000
| +80% | +$3.64M | 0.01% | 607 |
|
|
2025
Q3 | $4.63M | Hold |
20,000
| – | – | 0.01% | 811 |
|
|
2025
Q2 | $3.71M | Sell |
20,000
-184,800
| -90% | -$34.3M | 0.01% | 661 |
|
|
2025
Q1 | $42.9M | Buy |
204,800
+153,700
| +301% | +$29.9M | 0.08% | 163 |
|
|
2024
Q4 | $9.08M | Sell |
51,100
-11,300
| -18% | -$2.08M | 0.01% | 534 |
|
|
2024
Q3 | $12.3M | Buy |
62,400
+47,400
| +316% | +$8.85M | 0.03% | 385 |
|
|
2024
Q2 | $2.57M | Hold |
15,000
| – | – | ﹤0.01% | 865 |
|
|
2024
Q1 | $2.73M | Buy |
15,000
+4,900
| +49% | +$844K | 0.01% | 821 |
|
|
2023
Q4 | $1.57M | Sell |
10,100
-14,900
| -60% | -$2.17M | ﹤0.01% | 1046 |
|
|
2023
Q3 | $3.73M | Hold |
25,000
| – | – | 0.01% | 633 |
|
|
2023
Q2 | $3.37M | Sell |
25,000
-32,700
| -57% | -$4.8M | 0.01% | 597 |
|
|
2023
Q1 | $9.2M | Buy |
+57,700
| New | +$8.82M | 0.03% | 389 |
|
|
2022
Q3 | – | Sell |
-50,000
| Closed | -$7.68M | – | 1654 |
|
|
2022
Q2 | $7.68M | Buy |
+50,000
| New | +$7.64M | 0.03% | 421 |
|
|
2022
Q1 | – | Sell |
-150,000
| Closed | -$20.3M | – | 1930 |
|
|
2021
Q4 | $20.3M | Buy |
+150,000
| New | +$17.7M | 0.05% | 272 |
|
|
2021
Q1 | – | Sell |
-183,610
| Closed | -$19.7M | – | 1845 |
|
|
2020
Q4 | $19.7M | Hold |
183,610
| – | – | 0.03% | 287 |
|
|
2020
Q3 | $16.1M | Hold |
183,610
| – | – | 0.04% | 267 |
|
|
2020
Q2 | $18M | Buy |
183,610
+147,910
| +414% | +$13M | 0.06% | 196 |
|
|
2020
Q1 | $2.72M | Sell |
35,700
-103,400
| -74% | -$8.81M | 0.01% | 410 |
|
|
2019
Q4 | $12.3M | Hold |
139,100
| – | – | 0.05% | 275 |
|
|
2019
Q3 | $10.2M | Buy |
+139,100
| New | +$9.54M | 0.04% | 314 |
|
|
2018
Q2 | – | Sell |
-43,500
| Closed | -$4.12K | – | 1239 |
|
|
2018
Q1 | $4.12K | Sell |
43,500
-153,500
| -78% | -$16.9M | 0.01% | 611 |
|
|
2017
Q4 | $22.2M | Buy |
197,000
+41,000
| +26% | +$3.86M | 0.04% | 267 |
|
|
2017
Q3 | $13.9M | Sell |
156,000
-50,000
| -24% | -$3.81M | 0.03% | 305 |
|
|
2017
Q2 | $14.9M | Buy |
206,000
+50,000
| +32% | +$3.36M | 0.04% | 256 |
|
|
2017
Q1 | $10.2M | Buy |
156,000
+6,000
| +4% | +$377K | 0.03% | 298 |
|
|
2016
Q4 | $9.39M | Buy |
150,000
+70,000
| +88% | +$4.27M | 0.02% | 387 |
|
|
2016
Q3 | $5.05M | Hold |
80,000
| – | – | 0.01% | 428 |
|
|
2016
Q2 | $4.94M | Buy |
+80,000
| New | +$4.87M | 0.02% | 442 |
|
|
2015
Q4 | – | Sell |
-279,700
| Closed | -$15.3M | – | 1824 |
|
|
2015
Q3 | $15.3M | Sell |
279,700
-95,300
| -25% | -$6.2M | 0.05% | 174 |
|
|
2015
Q2 | $24.9M | Buy |
+375,000
| New | +$24.5M | 0.07% | 129 |
|
|
2015
Q1 | – | Sell |
-149,900
| Closed | -$9.69M | – | 1695 |
|
|
2014
Q4 | $9.69M | Buy |
149,900
+72,400
| +93% | +$4.56M | 0.03% | 365 |
|
|
2014
Q3 | $4.46M | Buy |
+77,500
| New | +$4.3M | 0.01% | 743 |
|
Other funds holding ABBV
VCM
VPM
Nomura Holdings's ABBV Position: Q1 2026 in Review
Nomura Holdings reduced its AbbVie (ABBV) stake by 68% in Q1 2026, selling an estimated $5.45M and leaving 11,792 shares worth $2.56M. The position accounts for 0.01% of the portfolio, ranked #845.
Nomura Holdings first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. The position peaked at $115M in Q3 2019. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Nomura Holdings held 11,792 shares of AbbVie worth $2.56M as of Q1 2026.
- Nomura Holdings sold 24,575 AbbVie shares in Q1 2026, an estimated $5.45M.
- AbbVie made up 0.01% of Nomura Holdings's portfolio in Q1 2026, its #845 holding.
- Nomura Holdings first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
- Nomura Holdings's AbbVie position peaked at $115M in Q3 2019.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.